I48.1
Conditions
Interventions
Group 1: Patients with an indication for an interventional atrial appendage closure and successful procedure are involved in our study after giving their informed consent. Patients undergo an Evaluati
Sponsors
Universitätsklinikum Magdeburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 18 years; both gender; all ethnic Groups; Weight: no Limitation; women: excluded pregnancy; procedure: successful interventional closure of the left atrial appendage.
Exclusion criteria
Exclusion criteria: Patients with known coronary heart disease or instable angina pectoris, severe valvular heart disease, severe diastolic dysfunction, severe pulmonary hypertension, anaemia, acute infection with fever and increase of C reactive protein and/or leukocytosis, isolated leukocytosis, increased C reactive protein, severe renal or liver insufficiency, neoplasia, pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcome measure is the proof of a significant Change in the neurohumoral Response to hemodynamic overload after successful closure of the left atrial appendage | — |
Secondary
| Measure | Time frame |
|---|---|
| Thrombogenesis and position of the atrial appendage closure device in the transesophageal echocardiography 45 days and 6 months after the Implantation prozedure. | — |
Countries
Germany
Contacts
Public ContactBlerim Luani
Universitätsklinikum MagdeburgKlinik für Kardiologie und Angiologie
Outcome results
None listed